导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -5.00% | 705/1050 |
| 近一周 | -3.79% | 943/1104 |
| 近一月 | -13.26% | 1093/1102 |
| 近一季 | 12.74% | 66/1092 |
| 近半年 | 0.80% | 404/1070 |
| 近一年 | -20.75% | 912/1018 |
| 近两年 | 30.94% | 670/926 |
| 近三年 | -3.93% | 707/834 |
| 成立以来 | 75.78% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-1.96% 644/1070 |
-3.97% 770/1101 |
- - |
- - |
| 2025 | 28.02% 510/1065 |
10.96% 127/1014 |
8.02% 157/1038 |
23.88% 486/1050 |
-13.79% 967/1065 |
| 2024 | -19.23% 897/1011 |
-11.36% 806/960 |
-8.86% 822/983 |
11.15% 537/991 |
-10.05% 899/1011 |
| 2023 | -19.52% 660/952 |
-0.19% 639/880 |
-12.56% 821/895 |
-3.15% 213/915 |
-4.78% 478/952 |
| 2022 | -24.96% 496/867 |
-16.59% 337/773 |
0.78% 682/806 |
-13.88% 509/845 |
3.65% 257/867 |
| 2021 | 3.82% 319/740 |
0.74% 121/580 |
22.28% 127/659 |
-8.94% 480/704 |
-7.45% 628/740 |
| 2020 | 89.62% 58/554 |
22.08% 6/419 |
50.04% 5/466 |
-3.98% 453/517 |
7.81% 396/554 |
| 2019 | 74.96% 19/410 |
37.84% 90/1146 |
5.37% 40/1228 |
13.59% 61/390 |
6.06% 308/410 |
| 2018 | -20.22% 85/349 |
- - |
0.10% 611/2983 |
2.44% 122/2970 |
-17.33% 960/1080 |
| 2017 | 9.47% 134/285 |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 创金合信医疗保健股票A VS. 东吴新产业精选股票A(580008) |